Skip to main content
Contact Us
Subscribe
E-Edition
40°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
GoodRx Holdings, Inc. - Class A Common Stock
(NQ:
GDRX
)
5.040
+0.010 (+0.20%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about GoodRx Holdings, Inc. - Class A Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
GoodRx Appoints Christopher A. McGinnis as Chief Financial Officer
February 05, 2025
From
GoodRx
Via
Business Wire
GoodRx Announces Date for Fourth Quarter and Full Year 2024 Earnings Release and Conference Call
January 30, 2025
From
GoodRx Holdings, Inc.
Via
Business Wire
Scott Wagner Joins GoodRx Board of Directors
January 22, 2025
From
GoodRx Holdings, Inc.
Via
Business Wire
GoodRx Offering Free Telehealth Appointments to Los Angeles Residents Affected by Wildfires
January 10, 2025
From
GoodRx
Via
Business Wire
GoodRx Unleashes “GoodRx for Pets,” Simplifying Access and Reducing Costs for Pet Medications
January 07, 2025
From
GoodRx
Via
Business Wire
GoodRx to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
December 18, 2024
From
GoodRx Holdings, Inc.
Via
Business Wire
GoodRx Report Shows Millions at Risk as Endocrinologist Shortages Hit Nearly 70% of U.S. Counties
December 17, 2024
From
GoodRx
Via
Business Wire
GoodRx Appoints Healthcare Industry Veteran, Wendy Barnes, as New Chief Executive Officer
December 16, 2024
From
GoodRx Holdings, Inc.
Via
Business Wire
GoodRx Reveals Americans Overspent on Weight Loss Medications by $200 Million This Year, Fills Still Surged
December 05, 2024
From
GoodRx
Via
Business Wire
GOODRX ALERT: Bragar Eagel & Squire, P.C. is Investigating GoodRx Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
November 12, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
GoodRx Reports Third Quarter 2024 Results
November 07, 2024
From
GoodRx Holdings, Inc.
Via
Business Wire
GoodRx to Participate in Upcoming Investor Conferences
November 04, 2024
From
GoodRx Holdings, Inc.
Via
Business Wire
GoodRx Unveils New E-commerce Platform, Launches with Opill®
October 31, 2024
From
GoodRx
Via
Business Wire
GoodRx Announces Exclusive Low Cash Price for QSYMIA®, the Leading Branded Once-Daily Oral Weight Management Medication for Adults
October 29, 2024
From
GoodRx
Via
Business Wire
Ronald E. Bruehlman Joins GoodRx Board of Directors
October 28, 2024
From
GoodRx
Via
Business Wire
GoodRx Announces New Affordability Programs for Menopause Hormone Therapies
October 23, 2024
From
GoodRx
Via
Business Wire
GoodRx Partnering with Retail Pharmacies to Deliver Pay-Over-Time Option Directly to Consumers
October 16, 2024
From
GoodRx
Via
Business Wire
GoodRx Announces Date for Third Quarter 2024 Earnings Release and Conference Call
October 10, 2024
From
GoodRx Holdings, Inc.
Via
Business Wire
GoodRx Announces Lowest Discounted Cash Price at Retail Pharmacy Locations for neffy® (epinephrine nasal spray)
September 26, 2024
From
GoodRx
Via
Business Wire
GOODRX ALERT: Bragar Eagel & Squire, P.C. is Investigating GoodRx Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
September 25, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
GoodRx to Participate in Upcoming Investor Conferences
August 21, 2024
From
GoodRx Holdings, Inc.
Via
Business Wire
GoodRx Reports Second Quarter 2024 Results
August 08, 2024
From
GoodRx Holdings, Inc.
Via
Business Wire
GoodRx Announces Date for Second Quarter 2024 Earnings Release and Conference Call
July 11, 2024
From
GoodRx Holdings, Inc.
Via
Business Wire
Ian T. Clark Joins GoodRx Board of Directors
July 10, 2024
From
GoodRx Holdings, Inc.
Via
Business Wire
GoodRx Launches New “Prescription Cost Tracker” to Spotlight Key Factors Driving Out-of-Pocket Medication Costs in the U.S.
June 26, 2024
From
GoodRx
Via
Business Wire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of GoodRx
June 21, 2024
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
GDRX Investors Have Opportunity to Lead GoodRx Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
June 21, 2024
From
The Schall Law Firm
Via
Business Wire
GoodRx Holdings, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - GDRX
June 21, 2024
From
DJS Law Group
Via
Business Wire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against GoodRx Holdings, Inc. (GDRX)
June 20, 2024
From
The Law Offices of Frank R. Cruz
Via
Business Wire
GDRX Investors Have Opportunity to Lead GoodRx Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
June 20, 2024
From
The Schall Law Firm
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
